RRx-001
| CAS No. | 925206-65-1 | Cat. No. | BCP19228 |
| Name | RRx-001 | ||
| Synonyms | RRx001;RRx 001; ABDNAZ; | ||
| Formula | C5H6BrN3O5 | M. Wt | 268.02 |
| Description | RRX-001 is a dinitroazetidine derivative with potential radiosensitizing activity. Upon administration, RRx-001 is able to dilate blood vessels, thereby increasing tumor blood flow and thus improving oxygenation to the tumor site. By increasing oxygen levels, these tumor cells may be more susceptible to radiation therapy. Tumor hypoxia is correlated with tumor aggressiveness, metastasis and resistance to radiotherapy. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antiparasitics | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.